Compounds > celecoxib

celecoxib and pyrimidinones

celecoxib has been researched along with pyrimidinones in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sanyal, SN; Vaish, V1
Baheti, KG; Ganorkar, SB; Shelke, RU; Yewale, SB1
Armeanu-Ebinger, S; Ellerkamp, V; Fuchs, J; Lieber, J; Nagel, C; Warmann, SW; Wenz, J1
Atefi, M; Avramis, E; Cass, A; Cochran, AJ; Comin-Anduix, B; Escuin-Ordinas, H; Fu, Y; Graeber, TG; Herschman, HR; Huang, RR; Lo, RS; Marais, R; Ng, C; Ribas, A; Yashar, S1
Ashour, HM; Fahmy, SM; Ibrahim, TM; Khalil, MA; Labouta, IM; Nassra, RA; Tageldin, GN1

Other Studies

5 other study(ies) available for celecoxib and pyrimidinones

ArticleYear
Non steroidal anti-inflammatory drugs modulate the physicochemical properties of plasma membrane in experimental colorectal cancer: a fluorescence spectroscopic study.
    Molecular and cellular biochemistry, 2011, Volume: 358, Issue:1-2

    Topics: 1,2-Dimethylhydrazine; 2-Naphthylamine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Celecoxib; Cell Membrane; Chemical Phenomena; Colorectal Neoplasms; Cyclooxygenase 2; Laurates; Male; Membrane Fluidity; Microscopy, Fluorescence; Phosphatidylethanolamines; Pyrazoles; Pyrimidinones; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence; Sulfonamides; Sulindac; Viscosity

2011
Novel 3-substituted-1-aryl-5-phenyl-6-anilinopyrazolo[3,4-d]pyrimidin-4-ones: docking, synthesis and pharmacological evaluation as a potential anti-inflammatory agents.
    Bioorganic & medicinal chemistry letters, 2012, Nov-01, Volume: 22, Issue:21

    Topics: Animals; Anti-Inflammatory Agents; Celecoxib; Diclofenac; Dose-Response Relationship, Drug; Edema; Molecular Structure; Protein Binding; Pyrazoles; Pyrimidinones; Rats; Sulfonamides

2012
Pharmacological inhibition of beta-catenin in hepatoblastoma cells.
    Pediatric surgery international, 2013, Volume: 29, Issue:2

    Topics: Antineoplastic Agents; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Etodolac; Hepatoblastoma; Humans; Liver Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Mas; Pyrazoles; Pyrimidinones; Sulfonamides; Tissue Distribution; Tumor Cells, Cultured

2013
COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors.
    Molecular oncology, 2014, Volume: 8, Issue:2

    Topics: Animals; Carcinoma, Squamous Cell; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Indoles; Keratoacanthoma; Melanoma; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrazoles; Pyridones; Pyrimidinones; Skin Neoplasms; Sulfonamides; Vemurafenib

2014
Synthesis, modeling and biological evaluation of some pyrazolo[3,4-d]pyrimidinones and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidinones as anti-inflammatory agents.
    Bioorganic chemistry, 2019, Volume: 90

    Topics: Animals; Anti-Inflammatory Agents; Binding Sites; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Edema; Female; Granuloma; Inflammation; Molecular Docking Simulation; Molecular Structure; Pyrazoles; Pyrimidinones; Rats, Wistar; Structure-Activity Relationship; Triazoles

2019